Segui
Piotr Stępniak
Piotr Stępniak
ExploRNA Therapeutics
Email verificata su explorna.com - Home page
Titolo
Citata da
Citata da
Anno
Detailed mechanism of squalene epoxidase inhibition by terbinafine
M Nowosielski, M Hoffmann, LS Wyrwicz, P Stepniak, DM Plewczynski, ...
Journal of chemical information and modeling 51 (2), 455-462, 2011
1272011
Expanding the set of rhodococcal Baeyer–Villiger monooxygenases by high-throughput cloning, expression and substrate screening
A Riebel, HM Dudek, G De Gonzalo, P Stepniak, L Rychlewski, ...
Applied microbiology and biotechnology 95, 1479-1489, 2012
1022012
Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients
R Duchnowska, J Jassem, CP Goswami, M Dundar, Y Gökmen-Polar, L Li, ...
Journal of Neuro-oncology 122, 205-216, 2015
782015
Mapping the substrate binding site of phenylacetone monooxygenase from Thermobifida fusca by mutational analysis
HM Dudek, G de Gonzalo, DE Torres Pazmiño, P Stępniak, LS Wyrwicz, ...
Applied and environmental microbiology 77 (16), 5730-5738, 2011
632011
Double site saturation mutagenesis of the human cytochrome P450 2D6 results in regioselective steroid hydroxylation
M Geier, A Braun, P Fladischer, P Stepniak, F Rudroff, C Hametner, ...
The FEBS journal 280 (13), 3094-3108, 2013
212013
Community assessment of the predictability of cancer protein and phosphoprotein levels from genomics and transcriptomics
M Yang, F Petralia, Z Li, H Li, W Ma, X Song, S Kim, H Lee, H Yu, B Lee, ...
Cell systems 11 (2), 186-195. e9, 2020
202020
Natural compounds as inhibitors of tyrosyl-tRNA synthetase
M Skupińska, P Stępniak, I Łętowska, L Rychlewski, M Barciszewska, ...
Microbial Drug Resistance 23 (3), 308-320, 2017
152017
AI aided design of epitope-based vaccine for the induction of cellular immune responses against SARS-CoV-2
G Mazzocco, I Niemiec, A Myronov, P Skoczylas, J Kaczmarczyk, ...
Frontiers in Genetics 12, 602196, 2021
92021
New approach to genomics experiments taking advantage of virtual laboratory system
H Luiza, L Marcin, S Piotr, F Marek, S Maciej, W Jan
CMST 15 (1), 31-40, 2009
72009
Microarray Inspector: tissue cross contamination detection tool for microarray data.
P Stępniak, M Maycock, K Wojdan, M Markowska, S Perun, A Srivastava, ...
Acta biochimica Polonica 60 (4), 647-655, 2013
52013
Review computational characterisation of cancer molecular profiles derived using next generation sequencing
U Oleksiewicz, K Tomczak, J Woropaj, M Markowska, P Stępniak, ...
Contemporary Oncology/Współczesna Onkologia 2015 (1), 78-91, 2015
42015
Mikromacierze DNA-analiza danych
P Stepniak, L Handschuh, M Figlerowicz
Biotechnologia, 68-87, 2008
42008
DNA microarray data analysis
P Stępniak, L Handschuh, M Figlerowicz
Biotechnologia 4 (83), 68-87, 2008
32008
AI-augmented design of effective therapeutic cancer vaccines and adoptive cell therapies
P Stepniak, G Mazzocco, A Myronov, I Niemiec, K Gruba, P Skoczylas, ...
Journal For Immunotherapy Of Cancer 7, 2019
12019
Smooth muscle contamination analysis in clinical oncology gene expression research.
M Markowska, P Stępniak, K Wojdan, K Świrski
Acta Biochimica Polonica 61 (2), 2014
12014
Virtual laboratory and its application in genomics
L Handschuh, M Lawenda, N Meyer, P Stȩpniak, M Figlerowicz, ...
Remote Instrumentation and Virtual Laboratories: Service Architecture and …, 2010
12010
DNA microarray data anlysis
P Stepniak, L Handschuh, M Figlerowicz
Biotechnologia 4, 68-87, 2008
12008
827 Streamlining design of safe and effective TCR therapies with AI
M Mizera, A Sanecka-Duin, M Jasiński, P Król, G Mazzocco, ...
Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021
2021
Accounting for immune escape mechanisms in personalized and shared neoantigen cancer vaccine design
A Myronov, I Niemiec, K Gruba, G Mazzocco, A Sanecka-Duin, ...
Cancer Research 80 (16), 2020
2020
Epitopes targeted by T cells in convalescent COVID-19 patients (preprint)
AA Quadeer, SF Ahmed, MR McKay, P Skoczylas, J Kaczmarczyk, ...
2020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20